• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Class 2 Device Recall BD Alaris" Pump Module

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
 Class 2 Device Recall BD Alaris" Pump Modulesee related information
Date Initiated by FirmJanuary 23, 2025
Date PostedFebruary 24, 2025
Recall Status1 Open3, Classified
Recall NumberZ-1231-2025
Recall Event ID 96069
510(K)NumberK211218 
Product Classification Pump, infusion - Product Code FRN
ProductBD Alaris Pump Module REF 8100 The BD Alaris System with Guardrails Suite MX is a modular infusion pump and monitoring system for the continuous or intermittent administration of fluids to adult, pediatric, and neonatal patients through clinically accepted routes of administration
Code Information Catalog Number: 8100 UDI-DI codes: 10885403810046 10885403517723 Software Version: 12.1.2 Serial/Lot Numbers: Pending
Recalling Firm/
Manufacturer
CareFusion 303, Inc.
10020 Pacific Mesa Blvd
San Diego CA 92121-4386
For Additional Information ContactConnor L. Bates
619-614-3771
Manufacturer Reason
for Recall
Due to User Manual/Direction for Use incorrectly instructing user to leave the safety clamp in the open position when reloading an infusion set. This issue potentially could result in an accidental over infusion if the roller clamp is left open.
FDA Determined
Cause 2
Under Investigation by firm
ActionOn 01/23/2025, the firm sent via FedEx, 2-day mail and email an "URGENT MEDICAL DEVICE LABELING CORRECTION" Letter to customers informing them that Through an internal review, BD has identified that in the BD Alaris" System User Manual v 12.3.1 (p/n #P00000455), 12.3.2 (p/n# P00000827) and 12.4 (p/n# P00000828), there is an incorrect note on the Pump Module Set Loading instructions. The manuals incorrectly instruct users to leave the safety clamp in the open position when reloading an infusion set. The correct procedure is to leave the safety clamp in the closed position. Following the incorrect note could potentially disable a safety feature that could result in an accidental over-infusion if the roller clamp is left open. Customers are instructed to: 1. Post the Customer Notification on or near the affected systems as a reminder of the incorrect labeling issue until the Manual/Directions for Use (DFU) have been corrected. 2. Complete the attached Customer Response Form and return to the BD contact noted on the form within 14 days, so that BD may acknowledge your receipt of this notification per FDA requirements and prioritize remediation scheduling. Actions BD is taking: 1. BD is in the process of updating the impacted user manuals. 2. BD will send customers follow-up notifications once the update of user manuals is completed. BD expects an updated user manual to be available by April 2025. For Questions or assistance: Contact - North American Regional Complaint Center for Product Complaints and Technical Questions at: Phone: 1-844-8BD-LIFE (1-844-823-5433) Say Product Complaints when prompted. Mon Fri 8:00am and 5:00pm CT or Email: productcomplaints@bd.com Contact Post Market Quality for Recall Questions at: Email : BDRC39@bd.com Fax No.: 312-949-0576
Quantity in Commerce242,098 systems
DistributionU.S.: AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, GU, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, PR, SC, SD, TN, TX, UT, VA, WA, WI, WV, WY and Guantanamo Bay, Cuba O.U.S.: Canada
Total Product Life CycleTPLC Device Report

1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 The manufacturer has initiated the recall and not all products have been corrected or removed. This record will be updated as the status changes.
510(K) Database510(K)s with Product Code = FRN
-
-